Stock

Lucira Health files for bankruptcy despite receiving FDA green light
The firm is seeking a strategic or financial partner for the resumption of manufacturing and development of additional home diagnostic testing products.
February 27, 2023
Business Deal Corporate Social
OpGen closes $7.5 million public offering
OpGen closed a public offering of an aggregate of 2.6 million shares of its common stock, Series A-1 warrants, to purchase the same amount of common stock and Series A-2 warrants at a combined public offering price of $2.90 per share.
January 17, 2023
Dollar Sign Social
OpGen announces one-for-20 reverse stock split
The reverse stock split, approved by its stockholders at a special meeting on November 30, has been implemented to increase the firm's share price so that it could regain compliance with Nasdaq’s minimum bid price listing requirement.
January 5, 2023
Stock Exchange Social
Argus Research initiates coverage of BioAffinity Technologies at $9 per share
BioAffinity's CyPath Lung lab-developed test uses flow cytometry and machine-learning algorithms to profile the approximately 20 million cells in an average sputum sample in less than 20 minutes.
December 19, 2022
Lung Cancer Social
Prometheus Biosciences announces $500M stock offering
The San Diego-based biotech company is taking a precision medicine approach for the discovery, development, and commercialization of therapeutic and companion diagnostic products for the treatment of immune-mediated diseases.
December 12, 2022
Business Graph Money Stocks Social
Blood volume diagnostic firm Daxor closes $2.1M offering of common stock
The New York firm plans to use the net proceeds to develop its products, fund capital expenditures, or invest in or acquire other businesses, among other potential uses.
November 17, 2022
Earning Stock Market Social
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Quest Diagnostics offers suite of services for transplant patients and living donors
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Genetron Health receives minimum-bid share price notification from Nasdaq
The company said it has 180 days, or until April 26, 2023, to regain compliance under the Nasdaq listing rules.
November 7, 2022
Business Financial Stock Drop Social
Quotient to effect reverse stock split, regain Nasdaq compliance
Its ordinary shares are expected to begin trading on the Nasdaq composite on a split-adjusted basis on November 3.
October 31, 2022
Stock Exchange
Epigenetics testing firm Cardio Diagnostics goes public on Nasdaq
At the core of its cardiovascular solutions is the Integrated Genetic-Epigenetic Engine, developed at the University of Iowa.
October 26, 2022
Heart Social
OpGen closes $3.38M offering to support U.S. commercialization of molecular panel
The firm announced it has closed a $3.38 million registered direct offering with a single institutional investor.
October 4, 2022
Dollar Sign
Biosensor developer Know Labs goes public on the NYSE
After the close of trading Thursday, the company announced the pricing of an underwritten public offering of 3.6 million shares at $2.00 per share; it granted to the underwriter a 45-day option to purchase up to 540,000 additional shares at the same price.
September 15, 2022
2022 03 21 22 38 5015 Money Bag Grant Award 400
BioAffinity Technologies goes public with $7.9M IPO
Gross proceeds from the offering are estimated to be about $7.9 million before deducting underwriting discounts and commissions and other estimated offering expenses.
August 31, 2022
2022 03 21 22 38 5015 Money Bag Grant Award 400
Page 1 of 3
Next Page